SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is currently in the spotlight as investors debate the impact of the upcoming CLARITY Act and the company's strategy of slowing its aggressive Ethereum accumulation. The community remains deeply divided, with some traders citing potential institutional pivot points and favorable tokenization trends, while others express frustration over share price performance compared to broader market gains and the company's dilution tactics.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Silver is experiencing a momentum breakout driven by intensifying industrial demand for AI infrastructure and renewed inflation hedging, leaving the community divided between aggressive buying of the dip and skepticism toward potential price manipulation. Investors are closely watching silvers decoupling from gold and its performance relative to rising treasury yields as the symbol gains traction as a strategic metal play.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors await critical extended follow-up data for its prostate cancer drug, CAN-2409, to be presented at an upcoming plenary session. The community is actively debating the potential for a practice-changing therapy, the durability of clinical outcomes, and the possibility of a premium acquisition by Big Pharma.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is gaining traction as investors pivot toward software leaders amid aggressive institutional stake-building from major hedge funds. The community is focused on the stock's potential for a breakout as it tests key technical resistance levels, with strong debate over its valuation compared to hardware-heavy AI plays.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is facing significant volatility following a weak first-quarter earnings report, which highlighted a net loss and production delays at its Thompson Falls smelter. Despite these operational setbacks, retail investors remain divided between frustration over the missed targets and a bullish long-term thesis centered on government grants and the stock's role as a critical domestic supplier of antimony and tungsten.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing significant community discussion due to its extremely tight float, with over 90% of shares reportedly held by the CEO and near-zero availability for shorting. Traders are closely watching for a potential parabolic squeeze, drawing comparisons to previous explosive meme stock moves and citing surging borrow fees as a catalyst for a possible short-covering rally.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is seeing intense retail activity and a significant price rally following a 100 million dollar strategic investment from the Winklevoss Capital Fund, which investors are interpreting as a major signal of institutional conviction. While the community remains divided over the stock's long-term viability and recent performance, traders are actively discussing the potential for a short squeeze due to high short interest and anticipation surrounding upcoming regulatory developments in the crypto sector.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is trending as investors highlight the company's strong revenue growth and expanding role in providing reliability testing for AI and electric vehicle semiconductor applications. The community is actively comparing its valuation and growth metrics to industry peers, leading to discussions about whether the stock is undergoing a significant re-rating.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run is capturing significant retail interest and surging on high volume following its recent de-SPAC transition and a strategic partnership announcement with CDW. Investors are actively debating the company's valuation compared to other AI infrastructure players while highlighting its NVIDIA-backed cloud status and substantial contracted revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>While the S&amp;P 500 closed up about 0.8% on Friday, the Nasdaq Composite rose 1.63%.&nbsp;</li><li>Trump announcements and solid corporate earnings drove significant rallies this week.</li></ul>U.S. equities closed out a highly active week on Friday, with the S&amp;P 500 and Nasdaq Composite ending the week near all-time highs, supported by strong earnings in the chipmaking and AI space, while policy support for cannabis and psychedelic research drove a few mid and small-cap pharma stocks higher.While the S&amp;P 500 closed up about 0.8% on Friday, marking its fourth consecutive week of gains, the Nasdaq Composite rose 1.63%. &nbsp;The following stocks clocked the highest gains this week:Akanda Corp. (<a href="https://stocktwits.com/symbol/AKAN">AKAN</a>): Shares of Akanda exploded this week, surging more than 300% after the Trump administration advanced plans to reclassify marijuana as a Schedule III drug. The broader cannabis sector ignited on the policy shift, and AKAN recorded single-day gains as high as 214%.Enveric Biosciences (<a href="https://stocktwits.com/symbol/ENVB">ENVB</a>): ENVB shares rocketed higher early in the week after President Trump’s executive order directing federal agencies to accelerate research and approval pathways for psychedelic therapies. The small-cap developer of psychedelic medicines for mental health surged more than 100% in a single session as investors bet on faster regulatory tailwinds in the sector. The company clocked its best week ever.MaxLinear (<a href="https://stocktwits.com/symbol/MXL">MXL</a>): MXL climbed sharply after the semiconductor company delivered a strong first-quarter earnings beat on Thursday and issued upbeat guidance that highlighted robust demand for its optical and connectivity chips in AI data centers. Revenue rose 43% year-over-year, beating estimates, and the raised outlook for the current quarter sent shares surging more than 75% in Friday’s session. The stock closed 130% higher this week, marking its best week to date.Trio-Tech International (<a href="https://stocktwits.com/symbol/TRT">TRT</a>): TRT stock soared as much as 67% on Thursday to a new all-time high as momentum traders piled into the stock. The company provides reliability testing services and specialized equipment that help chipmakers validate and stress-test products before they reach customers amid an overall increase in chip demand driven by AI infrastructure and data centers. The stock closed at $16.52 on Friday, after opening at just $7.05 at the week’s onset.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/arwr-rallies-this-week-as-europe-edges-closer-to-redemplo-approval-amid-analyst-optimism/cZBhLOHRecF">ARWR Rallies 7% This Week As Europe Edges Closer To Redemplo Approval Amid Analyst Optimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of GNTX rise on Friday (Representative image: Getty Images)

Cannabis, Psychedelics, And AI Stocks Are Wall Street’s Biggest Winners This Week

AKAN, ENVB, MXL, and TRT were the biggest gainers in the week ended April 24. 

Equity

AKAN, ENVB, MXL, and TRT were the biggest gainers in the week ended April 24. 


TRT for Massive Gains

If you’re tired of getting sand kicked in your portfolio’s face, some of these stocks are hitting the gym and flexing. Not every stock here is ripped yet, but several are clearly bulking, a few are cutting into definition, and one or two might already be stepping on stage. $KBLB, $TZOO, $TRT, $AKAN, $TXN, $AUUD, $REPL

Investors are bullishly comparing this stock to larger peers, arguing for a significant valuation re-rating driven by 124% revenue growth and semiconductor testing demand.

Traders are buzzing over the tight share structure and low market cap, believing the stock remains a hidden gem despite explosive growth metrics.

Strong recent orders and facility expansions in Malaysia are driving optimism that the company is effectively capturing long-term recurring AI and EV revenue.

Community discussions highlight increasing short interest relative to the limited float, fueling speculation of a potential squeeze as shares climb.

Current Price	$18.30
Prev Close	$14.02
Open	$15.00
Dividend Yield	0.00%
50-Day Moving Average	$8.39
Beta	0.50
Avg. Volume	2.2M
PE Ratio	-677.29

52-Week High	$19.10
52-Week Low	$2.31
Market Capitalization	$140.42M
EPS (Annual)	-$0.0048
Price to Book	3.66
Revenue Per Employee	$59,017.80

TRT
Trio-Tech International

Feed

News

Sentiment

Fundamentals

Info

Latest TRT News

TRTTrio-Tech International